
An announcement from Qualitas Controladora I ( ($MX:Q) ) is now available. Quálitas Controladora operates in the automobile insurance industry, with operations in Mexico, the United States, Peru, Costa Rica,
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| QUCOF | Qualitas Controladora I | 8.70 | 1.58 | 22.26% |
| Name | Price | % Change | |
|---|---|---|---|
| $8.70 | +22.26% |

An announcement from Qualitas Controladora I ( ($MX:Q) ) is now available. Quálitas Controladora operates in the automobile insurance industry, with operations in Mexico, the United States, Peru, Costa Rica,

Qualitas Controladora SAB de CV Class I (($MX:Q)) has held its Q3 earnings call. Read on for the main highlights of the call. Qualitas Controladora delivered a decidedly upbeat earnings

Qualitas Controladora I ( ($MX:Q) ) has provided an update. Quálitas reported a 7.7% rise in written premiums to MXN 18.66 billion in the third quarter of 2026 and a

Qualitas Controladora SAB de CV Class I (QUCOF) is scheduled to report 3rd quarter earnings on 10/20/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Qualitas Controladora

Qualitas Controladora SAB de CV Class I (QUCOF) is scheduled to report 3rd quarter earnings on 10/15/2026. Regarding Q3 estimates, Wall Street analysts expect Qualitas Controladora SAB de CV Class

An announcement from Qualitas Controladora I ( ($MX:Q) ) is now available. S&P Global Ratings has assigned Qualitas Compañía de Seguros a global financial strength and long-term issuer credit rating

Qualitas Controladora SAB de CV Class I (QUCOF) is scheduled to report 2nd quarter earnings on 07/21/2026, after the market closes. Regarding Q2 estimates, Wall Street analysts expect Qualitas Controladora

Qualitas Controladora SAB de CV Class I (QUCOF) is scheduled to report 2nd quarter earnings on 07/16/2026. Regarding Q2 estimates, Wall Street analysts expect Qualitas Controladora SAB de CV Class

Qualitas Controladora SAB de CV Class I (QUCOF) is scheduled to report 1st quarter earnings on 04/22/2026, after the market closes. Regarding Q1 estimates, Wall Street analysts expect Qualitas Controladora

Qualitas Controladora SAB de CV Class I (($MX:Q)) has held its Q4 earnings call. Read on for the main highlights of the call. Qualitas Balances Strong 2025 Results With VAT
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Oct 2, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Jan 28, 2027TBA | $3.93B | $0.17 | $1.17B | -62.36 | 16.36 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.